4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE

4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE
Generic 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE
Type
Formula C19H22N6O2
Weight Average: 366.417
Monoisotopic: 366.180423978
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE

Innovators Monograph

You find simplified version here 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447656
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444712
https://www.chemspider.com/Chemical-Structure.394687.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5551
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL121941
https://zinc.docking.org/substances/ZINC000005933198
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/N41
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide
(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE
(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
3,6,9,12,15-PENTAOXATRICOSAN-1-OL
(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID
2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID
CSF oligoclonal banding
Smear of duodenal fluid aspirate
Respiratory Syncytial Virus (RSV) Tests
Muscle biopsy
Galactose-1-phosphate uridyltransferase blood test
Secretin stimulation test
Lumbosacral spine x-ray
Quantitative nephelometry test
Drug Use Screening Tests
Sinus x-ray
Toxoplasmosis
Anal eczema
Candidemia
Chorioretinitis
Relapsed Chronic Lymphocytic Leukemia
PCSK1 Deficiency Obesity
Hand Disinfection
Stage T1 Bladder Papillary Urothelial Carcinoma
Type 1 Mucopolysaccharidosis
Bronchial irritation